Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice

Molecular Cancer Therapeutics

Volumn 8, Issue 9, 2009, Pages 2655-2663

  Warren, Mary Ann ^a   Shoemaker, Suzanne F ^a   Shealy, David J ^b   Bshara, Wiam ^a   Ip, Margot M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CNT 02213; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST TUMOR; CANCER INCIDENCE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; HETEROZYGOSITY; HOMOZYGOSITY; MALE; MOUSE; NONHUMAN; NULL ALLELE; ONCOGENE NEU; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR PROMOTION; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; BASE SEQUENCE; CARCINOGENS; DNA PRIMERS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349488509     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-09-0358     Document Type: Article

References (46)

1. Varela LM, Ip MM. Tumor necrosis factor-α: a multifunctional regulator of mammary gland development. Endocrinology 1996;137:4915-4924
2. Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR. Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue. Int J Cancer 1994;56:777-782 (Pubitemid 24102739)
3. Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 2002;13:135-141
4. van Horssen R, Ten Hagen TL, Eggermont AM. TNF-α in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 2006;11:397-408.
5. Ip MM, Shoemaker SF, Darcy KM. Regulation of rat mammary epithelial cell proliferation and differentiation by tumor necrosis factor α. Endocrinology 1992;130:2833-2844
6. Kaiser GC, Polk DB. Tumor necrosis factor α regulates proliferation in a mouse intestinal cell line. Gastroenterology 1997;112:1231-1240 (Pubitemid 27157535)
7. Wu S, Boyer CM, Whitaker RS, et al. Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res 1993;53:1939-1944 (Pubitemid 23127128)
8. Watanabe Y, Osaki H, Akaike T. TNF-α bifunctionally induces proliferation in primary hepatocytes: role of cell anchorage and spreading. J Immunol 1997;159:4840-4847 (Pubitemid 127471020)
9. Varela LM, Darcy KM, Ip MM. The epidermal growth factor receptor is not required for tumor necrosis factor-α action in normal mammary epithelial cells. Endocrinology 1997;138:3891-3900 (Pubitemid 27351944)
10. Lee PPH, Hwang JJ, Murphy G, Ip MM. Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Endocrinology 2000;141:3764-3773 (Pubitemid 30815701)
11. Shea-Eaton WK, Lee P-PH, Ip MM. Regulation of milk protein gene expression in normal mammary epithelial cells by tumor necrosis factor. Endocrinology 2001;142:2558-2568
12. Zhang HT, Zhang HW, Lee L, Ip MM. The liver-enriched inhibitory protein isoform of CCAAT/enhancer-binding protein β, but not nuclear factor- κB, mediates the transcriptional inhibition of β-casein by tumor necrosis factor-α. Endocrinology 2004;145:2833-2844 (Pubitemid 38686233)
13. Varela LM, Stangle-Castor NC, Shoemaker SF, Shea-Eaton WK, Ip MM. TNFα induces NFκB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. J Cell Physiol 2001;188:120-131
14. Stuelten CH, Byfield SD, Arany PR, Karpova TS, Stetler-Stevenson WG, Roberts AB. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β. J Cell Sci 2005;118:2143-2153
15. Sheen-Chen SM, Chen WJ, Eng HL, Chou FF. Serum concentration of tumor necrosis factor in patients with breast cancer. Breast Cancer Res Treat 1997;43:211-215 (Pubitemid 27173956)
16. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J 1999;18:2149-2164
17. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-1411 (Pubitemid 26354696)
18. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182
19. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A 1992;89:10578-10582
20. Ip MM, McGee SO, Masso-Welch PA, et al. The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice overexpressing erbB2 in the mammary epithelium. Carcinogenesis 2007;28:1269-1276
21. Darcy KM, Zangani D, Lee P-PH, Ip MM. Isolation and culture of normal rat mammary epithelial cells. In: Ip MM, Asch BB, editors. Methods in mammary gland biology and breast cancer research. NY: Kluwer Academic; 2000, p. 163-193
22. Banerjee MR, Chakraborty S, Kinder D, Manoharan K, Menon R. Cell biology of mouse mammary carcinogenesis in organ culture. In: Medina D, Kidwell W, Heppner G, Anderson E, editors. Cellular and molecular biology of mammary cancer. New York: Plenum; 1987, p. 353-379
23. Martin PL, Cornacoff JB, Treacy G, et al. Effects of administration of a monoclonal antibody against mouse tumor necrosis factor α during pregnancy and lactation on the pre- and postnatal development of the mouse immune system. Int J Toxicol 2008;27:341-347
24. Zhang J, Warren MA, Shoemaker SF, Ip MM. NFκB1/p50 is not required for TNF-stimulated growth of primary mammary epithelial cells: implications for NFκB2/p52 and RelB. Endocrinology 2007;148:268-278 (Pubitemid 46021459)
25. Rowse GJ, Ritland SR, Gendler SJ. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. Cancer Res 1998;58:2675-2679
26. Medina D. Mouse models for mammary cancer. In: Ip MM, Asch BB, editors. Methods in mammary gland biology and breast cancer research. New York: Kluwer Academic/Plenum Publishers; 2000, p. 3-17.
27. Schaefer FV, Tonelli QJ, Dickens MS, Custer RP, Sorof S. Nononcogenic hormone-independent alveoli produced by carcinogens in cultured mouse mammary glands. Cancer Res 1983;43:3310-3315
28. Marino MW, Dunn A, Grail D, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A 1997;94:8093-8098 (Pubitemid 27343782)
29. Moore RJ, Owens DM, Stamp G, et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 1999;5:828-831 (Pubitemid 29318619)
30. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H. Essential role of tumor necrosis factor α in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res 1999;59:4516-4518 (Pubitemid 29428949)
31. Scott KA, Moore RJ, Arnott CH, et al. An anti-tumor necrosis factor-α antibody inhibits the development of experimental skin tumors. Mol Cancer Ther 2003;2:445-451
32. Arnott CH, Scott KA, Moore RJ, et al. Tumour necrosis factor-α mediates tumour promotion via a PKC α- and AP-1-dependent pathway. Oncogene 2002;21:4728-4738
33. Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR. Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development. Oncogene 2004;23:1902-1910
34. Starcher B. Role for tumour necrosis factor-α receptors in ultraviolet-induced skin tumours. Br J Dermatol 2000;142:1140-1147 (Pubitemid 30418300)
35. Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 1993;91:2194-2206 (Pubitemid 23141496)
36. Kulbe H, Thompson R, Wilson JL, et al. The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 2007;67:585-592 (Pubitemid 46192196)
37. Knight B, Yeoh GCT, Husk KL, et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000;192:1809-1818 (Pubitemid 32049773)
38. Popivanova BK, Kitamura K, Wu Y, et al. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-570 (Pubitemid 351206546)
39. Oshima M, Oshima H, Matsunaga A, Taketo MM. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-α-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res 2005;65:9147-9151 (Pubitemid 41507975)
40. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-466 (Pubitemid 39329586)
41. Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB, Young PP. Low levels of tumor necrosis factor α increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res 2009;69:338-348
42. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008;117:244-279
43. Brown ER, Charles KA, Hoare SA, et al. A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer. Ann Oncol 2008;19:1340-1346
44. Madhusudan S, Foster M, Muthuramalingam SR, et al. A phase II study of etanercept (Enbrel), a tumor necrosis factor α inhibitor in patients with metastatic breast cancer. Clin Cancer Res 2004;10:6528-6534 (Pubitemid 39346547)
45. Madhusudan S, Muthuramalingam SR, Braybrooke JP, et al. Study of etanercept, a tumor necrosis factor-α inhibitor, in recurrent ovarian cancer. J Clin Oncol 2005;23:5950-5959 (Pubitemid 46300212)
46. Tsimberidou AM, Thomas D, O'Brien S, et al. Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies. Cancer Chemother Pharmacol 2002;50:237-242